Harrow Health, Inc.

Healthcare

NASDAQ:HROW · NASDAQ Global Market

Market Cap $1.40B Beta 0.28 P/E (TTM) -93.7

$37.64 -0.03%

-$0.01 today

52W Low $28.54High $54.85

Vol 0.74M · Avg 0.75M

EPS (TTM)-$0.40

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+24.18%

Period High

$54.80

Period Low

$29.03

Latest

$37.64

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Trevi Therapeutics, Inc.

NASDAQ:TRVI

$2.02B

Dynavax Technologies Corporation

DVAX

$1.82B

Alvotech

NASDAQ:ALVO

$1.30B

BioLife Solutions, Inc.

NASDAQ:BLFS

$1.28B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.22B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.12B

Evotec SE

NASDAQ:EVO

$966.11M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$885.83M

Tilray Brands, Inc.

NASDAQ:TLRY

$595.63M

Phreesia, Inc.

NYSE:PHR

$560.02M

What is the latest HROW filing?

The latest filing shown is 8-K dated Jun 3, 2026.

How many recent filings does HROW have?

Intrinsic Alpha currently shows 20 recent filings for HROW.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.